Please try another search
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s CELsignia diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Mothaffar F. Rimawi | - | 2019 | Member of Scientific Advisory Board |
Lee S. Schwartzberg | - | 2019 | Member of Scientific Advisory Board |
Richard E. Buller | 71 | 2019 | Independent Director |
Manfred Auer | - | - | Member of Scientific Advisory Board |
Mark D. Pegram | - | - | Member of Scientific Advisory Board |
Stanley M. Marks | 74 | - | Member of Scientific Advisory Board |
Adam M. Brufsky | - | - | Member of Scientific Advisory Board |
Lance G. Laing | 59 | 2012 | Co-Founder, Chief Science Officer, VP, Secretary & Director |
Brian F. Sullivan | 59 | 2012 | Co-Founder, Chairman & CEO |
Edward Greeno | - | - | Member of Scientific Advisory Board |
Richard J. Nigon | 74 | 2017 | Independent Director |
Carol Lange | - | - | Member of Scientific Advisory Board |
Ronald C. McGlennen | - | - | Member of Scientific Advisory Board |
Benita Katzenellenbogen | - | - | Member of Scientific Advisory Board |
Sara Hurvitz | - | - | Member of Scientific Advisory Board |
David F. Dalvey | 64 | 2014 | Independent Director |
John Katzenellengogen | - | - | Member of Scientific Advisory Board |
Leo T. Furcht | 75 | 2019 | Independent Director |
Ben Ho Park | - | 2020 | Member of Scientific Advisory Board |
Bora Lim | - | 2020 | Member of Scientific Advisory Board |
Hung Khong | - | 2021 | Member of Scientific Advisory Board |
Alberto Montero | - | 2021 | Member of Scientific Advisory Board |
Polly A. Murphy | 58 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review